HKPD

Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
HKPD
Market cap $15.6M

1.42 USD

+0.37

35.24%

At close Aug 26, 4:00 PM EDT

After hours

1.38

-0.04

2.82%

1 day

35.24%

5 days

30.28%

1 month

15.45%

3 months

18.33%

6 months

-17.92%

Year to date

-49.65%

1 year

-49.65%

5 years

-49.65%

10 years

-49.65%

About: Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.

Healthcare Pharmaceutical Retailers

0

Funds holding %

of 7,433 funds

–

Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

68% more capital invested

Capital invested by funds: $55.8K [Q1] → $93.5K (+$37.7K) [Q2]

50% more funds holding

Funds holding: 4 [Q1] → 6 (+2) [Q2]

0.2% more ownership

Funds ownership: 0.47% [Q1] → 0.67% (+0.2%) [Q2]

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for HKPD.

See Analyst Rankings

Financial journalist opinion

Hong Kong Pharma Digital Technology Holdings Limited Reports Financial Results for the Six Months Ended September 30, 2024

HONG KONG , March 28, 2025 /PRNewswire/ -- Hong Kong Pharma Digital Technology Holdings Limited (NASDAQ: HKPD) ("HKPD" or the "Company"), a leading provider of over the counter ("OTC") pharmaceutical cross-border e-commerce supply chain services in Hong Kong, today announced its unaudited financial results for the six months ended September 30, 2024. Financial Highlights for the Six Months Ended September 30, 2024: Net Revenues: The Company reported net revenues of $11, 091,189, an increase of 58.9% compared to $7,009,209 for the same period in 2023.

Hong Kong Pharma Digital Technology Holdings Limited Reports Financial Results for the Six Months Ended September 30, 2024

U.S. IPO Weekly Recap: Oil And Gas Well Equipment Provider Flowco Debuts, While More Sizable Deals Join The Pipeline

Three IPOs and three SPACs were listed this week. Eight issuers submitted initial filings this week, including a handful of sizable names. The US IPO market is set to host a historic event in the week ahead.

U.S. IPO Weekly Recap: Oil And Gas Well Equipment Provider Flowco Debuts, While More Sizable Deals Join The Pipeline

Hong Kong Pharma Digital Technology Holdings Limited Announces Closing of Initial Public Offering

NEW YORK , Jan. 16, 2025 /PRNewswire/ -- Hong Kong Pharma Digital Technology Holdings Limited ("Hong Kong Pharma" or the "Company") (NASDAQ: HKPD), a leading provider of over the counter ("OTC") pharmaceutical cross-border e-commerce supply chain services in Hong Kong, today announced the closing of its initial public offering (the "Offering") of an aggregate of 1,403,685 ordinary shares, par value $0.001 per share (the "Ordinary Shares") at a public offering price of US$4.00 per share of which 1,000,000 Ordinary Shares were offered by the Company, and 403,685 Ordinary Shares were offered by certain selling shareholders of the Company. Hong Kong Pharma did not receive any proceeds from the sale of ordinary shares by the selling shareholders.

Hong Kong Pharma Digital Technology Holdings Limited Announces Closing of Initial Public Offering

See News Rankings

Charts implemented using Lightweight Charts™